Keywords: mylan, sees, solid, third-quarter, results, usa-based, laboratories
Mylan sees solid third-quarter results
Article | 13 February 2006
USA-based Mylan Laboratories says that its revenue for the third quarter ended December 31, 2005, increased 7% to $311.2 million from $291.0 million in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
